8 news items
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
17 Jun 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed by Akero
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
10 Jun 24
) that, as a result of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
5 Jun 24
, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed by Akero
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
29 May 24
) that, as a result of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
22 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
ve4l2w7gi08cwiiua04vx4e95prr6wdhivawqr5a17ui9oc
ADSK
21 May 24
solution, and that's why we are excited to join a company that, at its core, supports the iterative nature of 3D and storytelling. We put a lot
ybyizfjr367vciaar9hh5o6s3xpa gnjvcq3gs12ldtvjo93bkqxmllj48bh
ADSK
AKRO
CMP
15 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
i9m49646b
ADSK
AKRO
CMP
8 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
- Prev
- 1
- Next